跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 46 条关于
“IVIRMA”
全部
46
临床试验
32
药物
2
机构
3
资讯
9
2个月前
ReproNovo Doses First Participant in EU Phase 2 NORDIC Trial of Oral Oxytocin Receptor Antagonist RPN-002 for Embryo Implantation
2个月前
Uterine Aging May Reduce Donor Egg Pregnancy Success After Age 49, Landmark Study Finds
9个月前
FDA Approves Novartis Gene Therapy Itvisma for Spinal Muscular Atrophy in Older Patients
4个月前
Novartis Receives Positive CHMP Opinion for Itvisma Gene Therapy for Spinal Muscular Atrophy
去年
Avirmax Biopharma Advances Novel Triple-Gene Therapy for Dry AMD with IND-Enabling Studies
去年
Avirmax Biopharma Doses First Patient in Phase I/IIa Trial of ABI-110 for Wet AMD
6个月前
Vima Therapeutics Raises $100M to Advance Oral Therapy for Movement Disorders
去年
Avirmax Biopharma Doses First Patient in Phase I/IIa Trial of ABI-110 Gene Therapy for Wet AMD and PCV
去年
Vima Therapeutics Emerges with $60M to Develop First Oral Therapy for Dystonia